Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acumen Pharmaceuticals Inc
(NQ:
ABOS
)
2.820
+0.200 (+7.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Other Filings
< Previous
1
2
3
4
Next >
Form 10QSB
Source:
SEC/Edgar
November 13, 2007
Form 8-K
Source:
SEC/Edgar
October 24, 2007
Form 8-K
Source:
SEC/Edgar
September 26, 2007
Form 8-K
Source:
SEC/Edgar
September 20, 2007
Form 8-K
Source:
SEC/Edgar
September 19, 2007
Form 8-K
Source:
SEC/Edgar
September 05, 2007
Form 10QSB
Source:
SEC/Edgar
August 13, 2007
Form 8-K
Source:
SEC/Edgar
July 17, 2007
Form 424B3
Source:
SEC/Edgar
June 28, 2007
Form EFFECT
Source:
SEC/Edgar
June 28, 2007
Form 424B3
Source:
SEC/Edgar
June 26, 2007
Form EFFECT
Source:
SEC/Edgar
June 24, 2007
Form SB-2
Source:
SEC/Edgar
June 21, 2007
Form DEF 14A
Source:
SEC/Edgar
June 14, 2007
Form PRE 14A
Source:
SEC/Edgar
June 03, 2007
Form SB-2
Source:
SEC/Edgar
May 31, 2007
Form 10QSB
Source:
SEC/Edgar
May 17, 2007
Form NT 10-Q
Source:
SEC/Edgar
May 15, 2007
Form REGDEX
Source:
SEC/Edgar
May 09, 2007
Form 8-K
Source:
SEC/Edgar
May 02, 2007
Form 8-K
Source:
SEC/Edgar
April 26, 2007
Form 8-K
Source:
SEC/Edgar
April 22, 2007
Form 10KSB
Source:
SEC/Edgar
April 16, 2007
Form 8-K
Source:
SEC/Edgar
April 03, 2007
Form 8-K
Source:
SEC/Edgar
April 02, 2007
Form NT 10-K
Source:
SEC/Edgar
April 02, 2007
Form 8-K
Source:
SEC/Edgar
February 07, 2007
Form 8-K
Source:
SEC/Edgar
November 15, 2006
Form 10QSB
Source:
SEC/Edgar
November 13, 2006
Form 8-K
Source:
SEC/Edgar
October 31, 2006
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.